Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EMMR | ISIN: US90042W1009 | Ticker-Symbol:
NASDAQ
06.06.25 | 22:00
0,361 US-Dollar
+5,25 % +0,018
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
TURNSTONE BIOLOGICS CORP Chart 1 Jahr
5-Tage-Chart
TURNSTONE BIOLOGICS CORP 5-Tage-Chart

Aktuelle News zur TURNSTONE BIOLOGICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
09.05.Turnstone Biologics GAAP EPS of -$0.512
TURNSTONE BIOLOGICS Aktie jetzt für 0€ handeln
09.05.Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights55SAN DIEGO, May 08, 2025 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. ("Turnstone" or the "Company") (Nasdaq-CM: TSBX), a biotechnology company historically focused on the development of a differentiated...
► Artikel lesen
31.03.Turnstone Biologics GAAP EPS of -$0.56 misses by $0.362
29.03.Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results396SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. ("Turnstone" or the "Company") (Nasdaq: TSBX), a biotechnology company historically focused on the development of a differentiated...
► Artikel lesen
05.02.Piper Sandler cuts Turnstone Biologics stock rating to neutral1
04.02.Turnstone ends last remaining clinical program due to costs, plots more layoffs1
04.02.Turnstone Biologics stoppt TIDAL-01-Entwicklung und sucht nach Alternativen1
04.02.Turnstone Biologics halts TIDAL-01 development, seeks alternatives4
04.02.Turnstone Biologics Corp.: Turnstone Biologics Announces Plans to Explore Strategic Alternatives152SAN DIEGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. ("Turnstone" or the "Company") (Nasdaq: TSBX) today announced that it has completed an assessment of its business and operations...
► Artikel lesen
04.02.Turnstone Biologics Corp. - 8-K, Current Report-
11.10.24Turnstone Biologics Corp.: Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway846Realigning resources to focus on clinical advancement of Selected TIL therapyReducing employee headcount by approximately 60%Streamlining operations with cash runway expected to extend into 2Q 2026...
► Artikel lesen
14.08.24Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights229Announced positive initial data from Phase 1 trial of TIDAL-01 in metastatic colorectal cancer including a complete response in one of the four patients reported Cash position expected to fund operations...
► Artikel lesen
14.08.24Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer205Overall response rate ("ORR") of 25% and 50% disease control rate ("DCR") observed in first four evaluable patients treated with TIDAL-01 with advanced CRC Complete response achieved in heavily pre-treated...
► Artikel lesen
13 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1